AAffirma Biotech — Seed (estimated) · €1.75M
Barcelona biotech Affirma Biotech raised €1.75 million led by Nara Capital to advance its immune-activating compounds for severe influenza and chronic hepatitis B. The company had previously raised about €1 million.
LeadNara Capital
RoundSeed (estimated)
Announced2 Feb 2024
CityBarcelona
SectorHealthtech & Bio · Biotech
Source
W
A
W
A
The company
Investors 7
NNara Capital
www.nara.capital
A
Alfons Hidalgo
BBCN Peptides
CCapital Cell
capitalcell.com
GGENESIS Biomed
genesis-biomed.com
Profile: GENESIS Ventures
RReig Jofre Investments
SSeedBlink